feed,title,long_url,short_url
Benzinga,"FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq",https://benzinga.com/general/biotech/23/05/32482878/fda-approves-first-oral-treatment-for-crohns-disease-making-seventh-approval-for-abbvies-rinvoq,https://da.gd/bnVaKG
Benzinga,Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket,https://benzinga.com/news/23/05/32483790/why-dxc-technology-shares-are-trading-lower-by-around-5-here-are-20-stocks-moving-premarket,https://da.gd/08USZ9
